Results 61 to 70 of about 645 (202)

Amebicidal Activity of Escherichia coli Nissle 1917 Against Entamoeba histolytica

open access: yesMicroorganisms
Amebiasis is a globally prevalent infection that can lead to fatal outcomes if not adequately treated. Conventional treatment with imidazoles often fails due to side effects and resistance, emphasizing the need for alternative therapies. The probiotic Escherichia coli Nissle 1917 (EcN) has shown potential in combating intestinal pathogens.
Vivian Moura-Oliveira   +9 more
openaire   +3 more sources

The Intermediate Subunit of the Gal/Galnac Lectin may Play a Role in Erythrophagocytosis in Entamoeba Histolytica [PDF]

open access: yes, 2016
Entamoeba histolytica is a parasite responsible for amebic dysentery and liver abscess in humans. This pathogen causes ~100,000 deaths annually in regions that cannot prevent the fecal-oral route of transmission.
Rock, Michelle Lynne
core   +1 more source

Synthesis and Reactions of Some New Diiodocoumarin Derivatives Bearing Side Chains and Some of Their Biological Activities [PDF]

open access: yes, 2011
The synthesis of 6,8-diiodocoumarin derivatives (2-6) by condensation of 3,5-diiodosalicylaldehyde (1) with active methylene compounds is described.
A H Bedair   +6 more
core  

Amoebicidal activity of cationic carbosilane dendrons derived with 4-phenylbutyric acid against Acanthamoeba griffini and Acanthamoeba polyphaga trophozoites and cysts. [PDF]

open access: yesSci Rep, 2022
López-Barona P   +8 more
europepmc   +1 more source

Public Health Rep [PDF]

open access: yes
195813567994PMCnull751

core  

Cardiovascular Safety of Hydroxychloroquine-Azithromycin in 424 COVID-19 Patients [PDF]

open access: yesMedicina (Kaunas), 2023
Million M   +6 more
europepmc   +2 more sources

Demodex-induced Lupus miliaris disseminatus faciei: A case report. [PDF]

open access: yesMedicine (Baltimore), 2020
Luo Y, Wu LX, Zhang JH, Zhou N, Luan XL.
europepmc   +1 more source

Home - About - Disclaimer - Privacy